Eyal Kamhi joined Ferring – BTG in 2013, and is responsible for managing the Development Department, which is an integral part of Global Pharmaceutical R&D organization.
The development department is in charge of developing manufacturing processes and analytical methods for recombinant proteins, for pre-clinical and clinical studies.
Eyal holds a Ph.D. in Molecular Biology from the Weizmann Institute of Science, and a B.Sc. in Biology Ben-Gurion university of the Negev, Israel .
